JP2008063271A - Antibacterial cosmetic - Google Patents
Antibacterial cosmetic Download PDFInfo
- Publication number
- JP2008063271A JP2008063271A JP2006242088A JP2006242088A JP2008063271A JP 2008063271 A JP2008063271 A JP 2008063271A JP 2006242088 A JP2006242088 A JP 2006242088A JP 2006242088 A JP2006242088 A JP 2006242088A JP 2008063271 A JP2008063271 A JP 2008063271A
- Authority
- JP
- Japan
- Prior art keywords
- antibacterial agent
- alkylene oxide
- group
- weight
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 47
- 230000000844 anti-bacterial effect Effects 0.000 title description 15
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 23
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 8
- 125000002723 alicyclic group Chemical group 0.000 claims abstract description 6
- 125000005529 alkyleneoxy group Chemical group 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 28
- 125000002947 alkylene group Chemical group 0.000 claims description 23
- 150000000180 1,2-diols Chemical class 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 13
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- 239000004287 Dehydroacetic acid Substances 0.000 claims description 3
- 238000007259 addition reaction Methods 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 229940061632 dehydroacetic acid Drugs 0.000 claims description 3
- 235000019258 dehydroacetic acid Nutrition 0.000 claims description 3
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims description 3
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004889 salicylic acid Drugs 0.000 claims description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- 229960003260 chlorhexidine Drugs 0.000 claims description 2
- 229940097042 glucuronate Drugs 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 1
- 229920002413 Polyhexanide Polymers 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 abstract description 17
- 231100000475 skin irritation Toxicity 0.000 abstract description 17
- 230000036556 skin irritation Effects 0.000 abstract description 17
- -1 n-octyl Chemical group 0.000 description 43
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 208000035824 paresthesia Diseases 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000003240 coconut oil Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000002280 amphoteric surfactant Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 125000000424 1,2-diol group Chemical group 0.000 description 4
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 125000001033 ether group Chemical group 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 125000005702 oxyalkylene group Chemical group 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- ZITKDVFRMRXIJQ-UHFFFAOYSA-N dodecane-1,2-diol Chemical compound CCCCCCCCCCC(O)CO ZITKDVFRMRXIJQ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OSOIQJGOYGSIMF-UHFFFAOYSA-N cyclopentadecanone Chemical compound O=C1CCCCCCCCCCCCCC1 OSOIQJGOYGSIMF-UHFFFAOYSA-N 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940043264 dodecyl sulfate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000001414 (2E)-2-(phenylmethylidene)octanal Substances 0.000 description 1
- HZYHMHHBBBSGHB-UHFFFAOYSA-N (2E,6E)-2,6-Nonadienal Natural products CCC=CCCC=CC=O HZYHMHHBBBSGHB-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- HZYHMHHBBBSGHB-DYWGDJMRSA-N (2e,6e)-nona-2,6-dienal Chemical compound CC\C=C\CC\C=C\C=O HZYHMHHBBBSGHB-DYWGDJMRSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- HZVFRKSYUGFFEJ-YVECIDJPSA-N (2r,3r,4s,5r)-7-phenylhept-6-ene-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=CC1=CC=CC=C1 HZVFRKSYUGFFEJ-YVECIDJPSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- BTOOAFQCTJZDRC-UHFFFAOYSA-N 1,2-hexadecanediol Chemical compound CCCCCCCCCCCCCCC(O)CO BTOOAFQCTJZDRC-UHFFFAOYSA-N 0.000 description 1
- PTSXVUICYWATQI-UHFFFAOYSA-N 1,2-tetracosanediol Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)CO PTSXVUICYWATQI-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- WNJSKZBEWNVKGU-UHFFFAOYSA-N 2,2-dimethoxyethylbenzene Chemical compound COC(OC)CC1=CC=CC=C1 WNJSKZBEWNVKGU-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- MPGABYXKKCLIRW-UHFFFAOYSA-N 2-decyloxirane Chemical compound CCCCCCCCCCC1CO1 MPGABYXKKCLIRW-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- FRPAVHFNOFSNDR-UHFFFAOYSA-N 3-(2,4-dioxo-1,3-thiazolidin-3-yl)propanoic acid Chemical compound OC(=O)CCN1C(=O)CSC1=O FRPAVHFNOFSNDR-UHFFFAOYSA-N 0.000 description 1
- KTCCLEVCNRHWQL-UHFFFAOYSA-N 3-(2-oxotridecylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)CNCCC(O)=O KTCCLEVCNRHWQL-UHFFFAOYSA-N 0.000 description 1
- AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 1
- WGVGLSURTKMQQC-UHFFFAOYSA-N 3-aminopropyl-ethyl-dimethylazanium Chemical compound CC[N+](C)(C)CCCN WGVGLSURTKMQQC-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 1
- 229940072717 alpha-hexylcinnamaldehyde Drugs 0.000 description 1
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- ZRGUXTGDSGGHLR-UHFFFAOYSA-K aluminum;triperchlorate Chemical compound [Al+3].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O ZRGUXTGDSGGHLR-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- PWZFXELTLAQOKC-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide;tetrahydrate Chemical compound O.O.O.O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O PWZFXELTLAQOKC-UHFFFAOYSA-A 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- RLPQZSVUADVLBS-UHFFFAOYSA-L disodium;3-hydroxypropyl phosphate Chemical compound [Na+].[Na+].OCCCOP([O-])([O-])=O RLPQZSVUADVLBS-UHFFFAOYSA-L 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- HQSFGCUUTBCFPF-UHFFFAOYSA-N ethane-1,2-diol;octadecanoic acid Chemical compound OCCO.CCCCCCCCCCCCCCCCCC(O)=O HQSFGCUUTBCFPF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-Undecalactone Natural products CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 description 1
- 229940020436 gamma-undecalactone Drugs 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 229940071180 lauryl sulfosuccinate Drugs 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- CBFCDTFDPHXCNY-UHFFFAOYSA-N octyldodecane Natural products CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
本発明は化粧品用抗菌剤、詳しくは、ジオールから誘導されるヒドロキシアルキルエーテル基を有する化合物を含有する抗菌剤に関するものである。 The present invention relates to an antibacterial agent for cosmetics, and more particularly to an antibacterial agent containing a compound having a hydroxyalkyl ether group derived from a diol.
従来、化粧品には製造時及び使用時における細菌、カビ等の雑菌混入による変質を防止するため、安息香酸及びその塩、イソプロピルメチルフェノール、パラオキシ安息香酸エステル(パラベン)、フェノキシエタノール、サリチル酸及びその塩、デヒドロ酢酸及びその塩、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化アルキルトリメチルアンモニウム等の抗菌剤が使用されてきた。しかしながら、これらの抗菌剤 は皮膚に対して刺激性があり、より安全な抗菌剤 が求められてきていた。
その後、従来から保湿剤として使用されている1,2−アルカンジオールが、比較的皮膚刺激性の低い抗菌剤として提案され、抗菌剤としての効果も優れていることが発表されている。(特許文献−1〜4)しかし、これらは比較的多くの添加量を必要とし、かつ1,2−アルカンジオールの特有の臭気を有していた。
これらの改良方法として、最近ではキレート剤との併用や、炭素数の異なる2種以上の1,2−アルカンジオールの併用などが提案されている。(特許文献5、6および非特許文献1〜3)
しかしながら、最近の生活者の安全性志向の高まりがある中で、従来以上にピリピリ感やヒリヒリ感が少なく、低アレルギー性で低刺激性の化粧品が望まれており、低添加量で従来以上の抗菌効果があり、かつ、皮膚刺激性が低い抗菌剤が望まれている。
Thereafter, 1,2-alkanediol, which has been used as a moisturizing agent, has been proposed as an antibacterial agent having relatively low skin irritation, and it has been announced that the effect as an antibacterial agent is also excellent. (Patent Documents 1 to 4) However, these required a relatively large amount of addition and had a characteristic odor of 1,2-alkanediol.
As these improvement methods, recently, combined use with a chelating agent, combined use of two or more 1,2-alkanediols having different carbon numbers, and the like have been proposed. (Patent Documents 5 and 6 and Non-Patent Documents 1 to 3)
However, with the recent increase in the safety orientation of consumers, cosmetics with less allergic and tingling sensations and less allergenic and less irritating are desired. An antibacterial agent having an antibacterial effect and low skin irritation is desired.
本発明は低添加量で、かつ、皮膚刺激性が低い化粧品用抗菌剤を提供しようとするものである。 The present invention is intended to provide a cosmetic antibacterial agent having a low additive amount and low skin irritation.
本発明者らは、上記の課題を解決すべく鋭意検討した結果、本発明に至った。
すなわち本発明は、一般式(1)で示される化合物の1種以上を含有してなる化粧品用抗菌剤、および該抗菌剤を0.01〜3重量%含有してなる化粧品である。
As a result of intensive studies to solve the above problems, the present inventors have reached the present invention.
That is, the present invention is a cosmetic antibacterial agent containing at least one compound represented by the general formula (1), and a cosmetic containing 0.01 to 3% by weight of the antibacterial agent.
式中、Rは炭素数6〜30の脂肪族または脂環式炭化水素基;AOは炭素数2〜6のアルキレンオキシ基;mおよびnは0または1〜30の整数であり、少なくとも一方は0ではない。 In the formula, R is an aliphatic or alicyclic hydrocarbon group having 6 to 30 carbon atoms; AO is an alkyleneoxy group having 2 to 6 carbon atoms; m and n are 0 or an integer of 1 to 30, and at least one of them is It is not zero.
本発明の化粧品用抗菌剤は抗菌性に優れ、かつ低皮膚刺激性である。従って、化粧品への配合量が少なくて済み、その化粧品は皮膚刺激性も低い。 The antibacterial agent for cosmetics of the present invention is excellent in antibacterial properties and has low skin irritation. Therefore, the amount to be added to the cosmetic is small, and the cosmetic has low skin irritation.
本発明の化粧品用抗菌剤は、一般式(1)で示される化合物の1種以上、好ましくは2種以上さらに好ましくは3〜10種を含有する。 The antibacterial agent for cosmetics of this invention contains 1 or more types of the compound shown by General formula (1), Preferably 2 or more types, More preferably, 3-10 types are contained.
一般式(1)において、Rは、好ましくは炭素数8〜20、さらに好ましくは8〜16であり、Rが炭素数6未満では十分な抗菌性が得られず、炭素数が30を超えると、化粧品への溶解性および相溶性が低下し、均一になりにくい。
Rのうちの脂肪族炭化水素基としては、直鎖または分岐のアルキル基(n−ヘキシル基、n−ヘプチル基、n−オクチル、n−デシル、ドデシル、テトラデシル、ヘキサデシル、オクタデシル、アイコシル、ドコシル、3,5,7−トリメチルオクチル基等)および直鎖または分岐のアルケニル基(1−ヘキセニル、1−デセニル、6−ドデセニル、オレイル基等)などが挙げられる。
Rのうちの脂環式炭化水素基としては、シクロアルキル基(シクロヘキシル等)、アル
キルシクロヘキシル基(プロピルシクロヘキシル基、オクチルシクロヘキシル基等)、シクロアルキルアルキル基(シクロヘキシルブチル基、シクロヘキシルオクチル基等)およびシクロアルケニル基(2−シクロヘキセニル基)などが挙げられる。
Rのうち好ましいのは、脂肪族炭化水素基であり、これらのうちの炭素数の異なる2種以上を併用してもよい。
In the general formula (1), R preferably has 8 to 20 carbon atoms, more preferably 8 to 16, and when R is less than 6 carbon atoms, sufficient antibacterial properties cannot be obtained, and when the carbon number exceeds 30 carbon atoms. , Cosmetic solubility and compatibility are reduced, and it is difficult to achieve uniformity.
Examples of the aliphatic hydrocarbon group in R include a linear or branched alkyl group (n-hexyl group, n-heptyl group, n-octyl, n-decyl, dodecyl, tetradecyl, hexadecyl, octadecyl, eicosyl, docosyl, 3,5,7-trimethyloctyl group, etc.) and linear or branched alkenyl groups (1-hexenyl, 1-decenyl, 6-dodecenyl, oleyl group, etc.).
Examples of the alicyclic hydrocarbon group in R include a cycloalkyl group (such as cyclohexyl), an alkylcyclohexyl group (such as propylcyclohexyl group and octylcyclohexyl group), a cycloalkylalkyl group (such as cyclohexylbutyl group and cyclohexyloctyl group), and the like. A cycloalkenyl group (2-cyclohexenyl group) etc. are mentioned.
Of these, R is preferably an aliphatic hydrocarbon group, and two or more of them may be used in combination.
一般式(1)におけるAOで示される炭素数2〜6のアルキレンオキシ基としては、エチレンオキシ基、1,2−プロピレンオキシ基、1,3−プロピレンオキシ基、1,2−ブチレンオキシ基、1,4−ブチレンオキシ基および1,6−へキシレンオキシ基などが挙げられる。AOのうち、抗菌性および皮膚刺激性の観点から好ましいのはエチレンオキシ基、1,2−プロピレンオキシ基およびこれらの併用である。 Examples of the alkyleneoxy group having 2 to 6 carbon atoms represented by AO in the general formula (1) include an ethyleneoxy group, a 1,2-propyleneoxy group, a 1,3-propyleneoxy group, a 1,2-butyleneoxy group, Examples include 1,4-butyleneoxy group and 1,6-hexyleneoxy group. Of the AOs, ethyleneoxy groups, 1,2-propyleneoxy groups, and combinations thereof are preferred from the viewpoint of antibacterial properties and skin irritation.
一般式(1)において、mおよびnは0または1〜30の整数、好ましくは0または1〜10の整数であり、mおよびnのうち少なくとも一方は0ではなく、m+nは1〜60、好ましくは1〜10の整数である。
mおよびnの両方が0である化合物としては、従来から公知の抗菌剤である1,2−アルカンジオールが挙げられるが、前述のように抗菌性と低皮膚刺激性において不十分である。
mおよびnの両方が0である化合物は、分子の末端に親水基としての1,2−ジオール基を有するが、本発明の抗菌剤は、一般式(1)に示されるように、少なくとも1つのヒドロキシアルキルエーテル基(−O−(AO)−H)を有する親水基を含有している。
微生物は増殖するためには必要最小限度の水分が必要であると従来から言われている。
1,2−ジオール基では隣接した炭素原子に水酸基が存在し親水基の占有体積が比較的小さいが、一般式(1)で示される抗菌剤は、ヒドロキシアルキルエーテル基を有することによって親水基が広がるとともに水酸基間の距離が離れることによって、1,2−ジオール基では得られないほどの多量の水和水を必要とし、微生物から水分を奪うため微生物の増殖を抑制しているものと推定される。
また、水分の非常に多い系では、1,2−ジオール基よりも一般式(1)に示されるような少なくとも1つのヒドロキシアルキルエーテル基(−O−(AO)−H)を有する親水基の方が微生物の細胞膜表面への吸着力が大きく、抗菌性が発揮しやすいものと推定される。
なお、本発明の抗菌剤は、その疎水基(一般式(1)におけるR)には好ましい炭素数があり、前述のように、好ましくは炭素数8〜20、さらに好ましくは8〜16であり、この炭素数の範囲であると、微生物の細胞膜に吸着されやすいので細胞膜の破壊に好都合であると推定される。
In the general formula (1), m and n are 0 or an integer of 1 to 30, preferably 0 or an integer of 1 to 10, and at least one of m and n is not 0, and m + n is 1 to 60, preferably Is an integer from 1 to 10.
The compound in which both m and n are 0 includes 1,2-alkanediol which is a conventionally known antibacterial agent, but is insufficient in antibacterial properties and low skin irritation as described above.
A compound in which both m and n are 0 has a 1,2-diol group as a hydrophilic group at the end of the molecule, but the antibacterial agent of the present invention has at least 1 as shown in the general formula (1). It contains a hydrophilic group with two hydroxyalkyl ether groups (—O— (AO) —H).
It has traditionally been said that microorganisms need a minimum amount of water to grow.
In the 1,2-diol group, a hydroxyl group is present at an adjacent carbon atom and the occupied volume of the hydrophilic group is relatively small. However, the antibacterial agent represented by the general formula (1) has a hydrophilic group by having a hydroxyalkyl ether group. As the distance between the hydroxyl groups increases and the distance between the hydroxyl groups increases, it is estimated that a large amount of water of hydration that cannot be obtained with the 1,2-diol group is required, and the growth of microorganisms is suppressed because it deprives the microorganisms of water. The
Further, in a system having a very high water content, a hydrophilic group having at least one hydroxyalkyl ether group (—O— (AO) —H) as shown in the general formula (1) rather than a 1,2-diol group is used. It is presumed that the microorganism has a higher adsorption power to the cell membrane surface, and easily exhibits antibacterial properties.
In the antibacterial agent of the present invention, the hydrophobic group (R in the general formula (1)) has a preferable carbon number, and as described above, preferably has 8 to 20 carbon atoms, more preferably 8 to 16 carbon atoms. In this range of carbon number, it is presumed that it is convenient for destruction of the cell membrane because it is easily adsorbed on the cell membrane of microorganisms.
また、本発明の抗菌剤は、一般式(1)で示される化合物を2種以上含むことが好ましい。
2種以上を含む場合、Rが異なる2種以上、Aが異なる2種以上、およびm+nが異なる2種以上などの場合がある。
これらのうち好ましいのはRが異なる2種以上およびm+nが異なる2種以上であり、さらに好ましいのはm+nが異なる2種以上であり、特にm+nが異なる3種以上、とりわけ異なる3〜10種を有することが好ましい。
m+nが異なる2種以上を有することによって、相乗的効果を発揮し抗菌性が向上し、低皮膚刺激性になり、さらには抗菌スペクトルが広くなる傾向にある。
Moreover, it is preferable that the antibacterial agent of this invention contains 2 or more types of compounds shown by General formula (1).
When two or more types are included, there may be two or more types with different R, two or more types with different A, and two or more types with different m + n.
Among these, 2 or more types with different R and 2 or more types with different m + n are preferable, 2 or more types with different m + n are more preferable, 3 or more types with different m + n are particularly preferable, and 3 to 10 different types are particularly preferable. It is preferable to have.
By having two or more different m + n types, a synergistic effect is exhibited, antibacterial properties are improved, skin irritation is reduced, and the antibacterial spectrum tends to be broadened.
本発明の化粧品用抗菌剤は、一般式(1)で示される化合物のm+nが異なる2種以上を含有する場合は、通常は、一般式(2)で示される1,2−ジオールにアルキレンオキサイドを付加反応させて得られるアルキレンオキサイド付加物である。 When the antibacterial agent for cosmetics of the present invention contains two or more compounds having different m + n of the compound represented by the general formula (1), the alkylene oxide is usually added to the 1,2-diol represented by the general formula (2). Is an alkylene oxide adduct obtained by addition reaction.
式中、Rは炭素数6〜30の脂肪族または脂環式炭化水素基である。 In the formula, R is an aliphatic or alicyclic hydrocarbon group having 6 to 30 carbon atoms.
アルキレンオキサイド付加物は、通常、アルキレンオキサイドの付加モル数の分布があり、付加モル数の異なる2種以上の化合物の混合物である。
本発明における1,2−ジオールの1分子当たりのアルキレンオキサイドの平均付加モル数は、好ましくは0.5〜10、さらに好ましくは0.5〜5、特に好ましくは0.5〜2である。
平均付加モル数が0.5以上であれば抗菌性が十分に発揮しやすく、かつ皮膚刺激性が十分に低い。また、平均付加モル数が10以下であれば抗菌性が十分に発揮し易い。
また、混合物を構成するそれぞれの化合物におけるアルキレンオキサイドの付加モル数は、好ましくは1〜30、さらに好ましくは1〜20、特に好ましくは1〜10である。
The alkylene oxide adduct is usually a mixture of two or more kinds of compounds having a distribution of the number of added moles of alkylene oxide and different numbers of added moles.
In the present invention, the average addition mole number of alkylene oxide per molecule of 1,2-diol is preferably 0.5 to 10, more preferably 0.5 to 5, and particularly preferably 0.5 to 2.
If the average number of added moles is 0.5 or more, the antibacterial property is easily exerted and the skin irritation is sufficiently low. Moreover, if the average number of added moles is 10 or less, the antibacterial property is sufficiently exerted.
The number of moles of alkylene oxide added in each compound constituting the mixture is preferably 1 to 30, more preferably 1 to 20, and particularly preferably 1 to 10.
なお、付加モル数が0の化合物、即ち、未反応1,2−ジオールは少ないほど好ましいが、1,2−ジオールに比較的少ないモル数のアルキレンオキサイドを付加反応させる場合に、未反応1,2−ジオールが残存しやすい。
未反応1,2−ジオールの含有量は、得られたアルキレンオキサイド付加物の重量(100重量%)に基づいて50重量%未満であることが好ましく、さらに好ましくは40重量%以下、特に好ましくは30重量%以下である。50重量%未満であれば、本発明の効果が発揮しやすく、臭気も少なく、抗菌性、低皮膚刺激性および低アレルギー性などの観点で好ましい。
なお、未反応1,2−ジオールが50重量%未満残存していても、そのアルキレンオキサイド付加物が共存していると、全体の抗菌性はアルキレンオキサイド付加物の効果が発現する傾向にある。
また、皮膚刺激性についても同様に、未反応1,2−ジオールを含有していても、その皮膚刺激性はアルキレンオキサイド付加物によって打ち消される傾向にある。
A compound having 0 addition moles, that is, less unreacted 1,2-diol is preferable. However, when a relatively small number of moles of alkylene oxide is added to 1,2-diol, unreacted 1, 2-diol tends to remain.
The content of unreacted 1,2-diol is preferably less than 50% by weight, more preferably 40% by weight or less, particularly preferably based on the weight (100% by weight) of the obtained alkylene oxide adduct. 30% by weight or less. If it is less than 50% by weight, the effects of the present invention are easily exerted, the odor is small, and it is preferable from the viewpoints of antibacterial properties, low skin irritation and hypoallergenicity.
Even if less than 50% by weight of unreacted 1,2-diol remains, if the alkylene oxide adduct coexists, the overall antibacterial properties tend to exhibit the effect of the alkylene oxide adduct.
Similarly, with regard to skin irritation, even when unreacted 1,2-diol is contained, the skin irritation tends to be canceled by the alkylene oxide adduct.
1,2−ジオールのアルキレンオキサイド付加物は、通常のアルキレンオキサイド付加反応によって製造することができる。 The alkylene oxide adduct of 1,2-diol can be produced by a usual alkylene oxide addition reaction.
例えば一般式(2)で表される1,2ジオールに、アルカリ性触媒(アルカリ金属水酸化物、アルカリ土類金属水酸化物、アルカリ土類金属酸化物など)または酸触媒(硫酸、塩酸などの無機酸、BF3などのルイス酸など)を使用して、温度90〜180℃、圧力0.3MPa以下で所定量のアルキレンオキサイドを圧入しながら反応させて得られる。
また、特開2002−114844号公報に記載の製造法における特定の触媒( Hammetの酸度関数による酸強度H0が−30.0〜−11.0の酸またはその金属塩、並びに シュレディンガーの波動方程式における最低空軌道が−10〜−3である金属の強酸塩など)を使用する製造法であってもよい。
For example, 1,2 diol represented by the general formula (2) may be added to an alkaline catalyst (alkali metal hydroxide, alkaline earth metal hydroxide, alkaline earth metal oxide, etc.) or acid catalyst (sulfuric acid, hydrochloric acid, etc.). Inorganic acids, Lewis acids such as BF 3 ), and the like, and a reaction is performed while injecting a predetermined amount of alkylene oxide at a temperature of 90 to 180 ° C. and a pressure of 0.3 MPa or less.
Further, a specific catalyst in the production method described in JP-A No. 2002-114844 (an acid having an acid strength H 0 by Hammett acidity function H 0 of −30.0 to −11.0 or a metal salt thereof, and Schrodinger's wave equation Or a strong acid salt of a metal having the lowest empty orbit in -10 to -3).
アルキレンオキサイドの付加モル数の分布は、試料を過剰のフェニルイソシアネート(試薬特級)と反応させて水酸基をラベル化した後、液体クロマトグラフィーによって、下記の条件で測定することができる。
機 種;島津製作所製 LC−10ADVP
カラム:μ−Porasil(Waters)
移動相;2%イソプロピルアルコール/ブチルクロライド〜
32%イソプロピルアルコール/ブチルクロライド
までグラディエント
検出器;UV(240nm)
温 度;40℃
各付加モル数のピークの面積をそれぞれ該当する付加モル数の化合物の分子量で割ったときの値の比から、各付加モル数の重量比を知ることができ、それに基づいて重量%を算出できる。
The distribution of the number of added moles of alkylene oxide can be measured under the following conditions by liquid chromatography after reacting a sample with an excess of phenyl isocyanate (special reagent grade) to label hydroxyl groups.
Model: LC-10ADVP manufactured by Shimadzu Corporation
Column: μ-Porasil (Waters)
Mobile phase: 2% isopropyl alcohol / butyl chloride
Gradient detector up to 32% isopropyl alcohol / butyl chloride; UV (240 nm)
Temperature: 40 ° C
From the ratio of the value obtained by dividing the peak area of each added mole number by the molecular weight of the corresponding added mole number compound, the weight ratio of each added mole number can be known, and the weight% can be calculated based on the ratio. .
本発明の化粧品用抗菌剤が、一般式(1)で示される化合物のうちの、mが1でnが0である化合物とmが0でnが1である化合物の2種の混合物である場合は、通常は、低分子量ジオール(エチレングリコール、プロピレングリコール、ブチレングリコールなどの炭素数2〜6のジオール)と長鎖脂肪族1,2−エポキシ化合物(例えば、1,2−エポキシドデカンなど)との反応によって得られる付加物であり、例えば、特開2003−96435号公報などに記載の方法で製造することができる。 The antibacterial agent for cosmetics of the present invention is a mixture of two compounds of a compound represented by the general formula (1) wherein m is 1 and n is 0 and a compound where m is 0 and n is 1. In general, low molecular weight diols (2 to 6 carbon diols such as ethylene glycol, propylene glycol and butylene glycol) and long chain aliphatic 1,2-epoxy compounds (for example, 1,2-epoxydodecane, etc.) For example, it can be produced by the method described in JP-A No. 2003-96435.
本発明の抗菌剤は、25℃で、通常は固状または液状であり、取り扱いのしやすさの観点から、好ましくは液状である。 The antibacterial agent of the present invention is usually solid or liquid at 25 ° C., and is preferably liquid from the viewpoint of ease of handling.
本発明の化粧品は、上記の本発明の化粧品用抗菌剤を必須成分とするものである。
本発明の化粧品は、通常は、さらに油剤、シリコーン化合物、アルコール類、ゲル化剤、アニオン性界面活性剤、ノニオン性界面活性剤、両性界面活性剤、カチオン性界面活性剤、キレート剤、pH調整剤、清涼剤、美白剤、保湿剤、コンディショニング剤、香料および着色料等の化粧品原料から選ばれる任意の成分を混合し、攪拌することにより得られる。
The cosmetic of the present invention comprises the above-described antibacterial agent for cosmetics of the present invention as an essential component.
The cosmetics of the present invention are usually further oils, silicone compounds, alcohols, gelling agents, anionic surfactants, nonionic surfactants, amphoteric surfactants, cationic surfactants, chelating agents, pH adjustments. It is obtained by mixing and stirring arbitrary components selected from cosmetic raw materials such as agents, refreshing agents, whitening agents, moisturizing agents, conditioning agents, fragrances and coloring agents.
前記油剤としては、例えば、オリーブ油、大豆油、ナタネ油、牛脂、豚脂、ラノリン、ステアリン酸、流動パラフィン等が挙げられる。 Examples of the oil include olive oil, soybean oil, rapeseed oil, beef tallow, lard, lanolin, stearic acid, and liquid paraffin.
前記シリコーン化合物としては、例えば、シリコン樹脂、メチルフェニルポリシロキサン、メチルポリシロキサン、オクタメチルシクロテトラシロキサン、ジメチルシロキサン・メチル(ポリオキシエチレン)シロキサン共重合体、デカメチルシクロペンタンシロキサン、ジメチルシロキサンメチル(ポリオキシエチレン・ポリオキシプロピレン)シロキサン共重合体、メチルハイドロジェンポリシロキサン、ドデカメチルシクロヘキサシロキサン、メチルポリシクロシロキサン、ジメチルシロキサン・メチルステアリキシシロキサン共重合体、メチルポリシロキサンエマルジョン、オクタメチルトリシロキサン、環状シリコン樹脂、高重合メチルポリシロキサン、テトラデカメチルヘキサシロキサン、トリメチルシロキシケイ酸などが挙げられる。 Examples of the silicone compound include silicone resin, methylphenylpolysiloxane, methylpolysiloxane, octamethylcyclotetrasiloxane, dimethylsiloxane / methyl (polyoxyethylene) siloxane copolymer, decamethylcyclopentanesiloxane, dimethylsiloxanemethyl ( Polyoxyethylene / polyoxypropylene) siloxane copolymer, methylhydrogenpolysiloxane, dodecamethylcyclohexasiloxane, methylpolycyclosiloxane, dimethylsiloxane / methylstearoxysiloxane copolymer, methylpolysiloxane emulsion, octamethyltrisiloxane , Cyclic silicon resin, highly polymerized methylpolysiloxane, tetradecamethylhexasiloxane, trimethylsiloxysilicate, etc. It is.
前記アルコール類としては、例えば、1価アルコール(メタノール、エタノール、イソプロピルアルコール、n−ブチルアルコール、ラウリルアルコール、ステアリルアルコールなど)、2〜6価の多価アルコール(エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、1,3−ブタンジオール、ジグリセリンおよびソルビトールなど)およびコレステロールなどが挙げられる。 Examples of the alcohols include monohydric alcohols (methanol, ethanol, isopropyl alcohol, n-butyl alcohol, lauryl alcohol, stearyl alcohol, etc.), 2-6 polyhydric alcohols (ethylene glycol, diethylene glycol, triethylene glycol, Polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butanediol, diglycerin and sorbitol) and cholesterol.
前記ゲル化剤としては、例えば、ショ糖パルミチン酸エステル、デキストリンステアリン酸エステル、モノベンジリデンソルビトール、N−ラウロイル−L−グルタミン酸等が挙げられる。 Examples of the gelling agent include sucrose palmitate, dextrin stearate, monobenzylidene sorbitol, N-lauroyl-L-glutamic acid, and the like.
前記アニオン性界面活性剤としては、炭素数8〜24の炭化水素系エーテルカルボン酸またはその塩、[(ポリ)オキシエチレンラウリルエーテル酢酸ナトリウム、(ポリ)オキシエチレンラウリルスルホコハク酸2ナトリウム等]、炭素数8〜24の炭化水素系硫酸エステル塩[ラウリル硫酸ナトリウム、(ポリ)オキシエチレンラウリル硫酸ナトリウム、(ポリ)オキシエチレンラウリル硫酸トリエタノールアミン、(ポリ)オキシエチレンヤシ油脂肪酸モノエタノールアミド硫酸ナトリウム、]、炭素数8〜24の炭化水素系スルホン酸塩[ドデシルベンゼンスルホン酸ナトリウム等]及び炭素数8〜24の炭化水素系リン酸エステル塩[ラウリルリン酸ナトリウム、(ポリ)オキシエチレンラウリルエーテルリン酸ナトリウム等]、脂肪酸塩[ラウリン酸ナトリウム、ラウリン酸トリエタノールアミン等]、アシル化アミノ酸塩[ヤシ油脂肪酸メチルタウリンナトリウム、ヤシ油脂肪酸ザルコシンナトリウム、ヤシ油脂肪酸ザルコシントリエタノールアミン、N−ヤシ油脂肪酸アシル−L−グルタミン酸トリエタノールアミン、N−ヤシ油脂肪酸アシル−L−グルタミン酸ナトリウム、ラウロイルメチル−β−アラニンナトリウム等]が挙げられる。 Examples of the anionic surfactant include hydrocarbon ether carboxylic acids having 8 to 24 carbon atoms or salts thereof, [sodium (poly) oxyethylene lauryl ether acetate, disodium (poly) oxyethylene lauryl sulfosuccinate, etc.], carbon Hydrocarbon sulfate salts of formula 8-24 [sodium lauryl sulfate, sodium (poly) oxyethylene lauryl sulfate, (poly) oxyethylene lauryl sulfate triethanolamine, (poly) oxyethylene coconut oil fatty acid sodium monoethanolamide sulfate, ], C8-24 hydrocarbon sulfonate [sodium dodecylbenzenesulfonate, etc.] and C8-24 hydrocarbon phosphate ester [sodium lauryl phosphate, (poly) oxyethylene lauryl ether phosphorus Acid sodium etc.], Fatty acid salts [sodium laurate, triethanolamine laurate, etc.], acylated amino acid salts [coconut oil fatty acid methyl taurine sodium, coconut oil fatty acid sarcosine sodium, coconut oil fatty acid sarcosine triethanolamine, N-coconut oil fatty acid acyl -L-glutamic acid triethanolamine, N-coconut oil fatty acid acyl-L-glutamic acid sodium, lauroylmethyl-β-alanine sodium, etc.].
前記ノニオン性界面活性剤としては、脂肪族系アルコール(炭素数8〜24)アルキレンオキサイド(炭素数2〜8)付加物、(ポリ)オキシアルキレン(炭素数2〜8)高級脂肪酸(炭素数8〜24)エステル[モノステアリン酸ポリエチレングリコール)、ジステアリン酸ポリエチレングリコール等]、多価(2価〜10価またはそれ以上)アルコール脂肪酸(炭素数8〜24)エステル[モノステアリン酸グリセリン、モノステアリン酸エチレングリコール、モノラウリン酸ソルビタン等]、(ポリ)オキシアルキレン(炭素数2〜8)多価(2価〜10価またはそれ以上)アルコール高級脂肪酸(炭素数8〜24)エステル[モノラウリン酸ポリオキシエチレンソルビタン、ポリオキシエチレンジオレイン酸メチルグルコシド等]、脂肪酸アルカノールアミド[1:1型ヤシ油脂肪酸ジエタノールアミド、1:1型ラウリン酸ジエタノールアミド等]、(ポリ)オキシアルキレン(炭素数2〜8)アルキル(炭素数1〜22)フェニルエーテル、(ポリ)オキシアルキレン(炭素数2〜8)アルキル(炭素数8〜24)アミノエーテルおよびアルキル(炭素数8〜24)ジアルキル(炭素数1〜6)アミンオキシド[ラウリルジメチルアミンオキシド等]等が挙げられる。 Examples of the nonionic surfactant include aliphatic alcohols (8 to 24 carbon atoms) alkylene oxide (2 to 8 carbon atoms) adducts, (poly) oxyalkylene (2 to 8 carbon atoms) higher fatty acids (8 carbon atoms). To 24) ester [polyethylene glycol monostearate], polyethylene glycol distearate, etc., polyvalent (divalent to 10-valent or more) alcohol fatty acid (carbon number 8 to 24) ester [glyceryl monostearate, monostearic acid Ethylene glycol, sorbitan monolaurate, etc.], (poly) oxyalkylene (2 to 8 carbon atoms) polyvalent (2 to 10 valent or higher) alcohol higher fatty acid (8 to 24 carbon atoms) ester [polyoxyethylene monolaurate] Sorbitan, polyoxyethylene dioleic acid methyl glucoside, etc.], Fatty acid alkanolamides [1: 1 type coconut oil fatty acid diethanolamide, 1: 1 type lauric acid diethanolamide, etc.], (poly) oxyalkylene (2 to 8 carbon atoms) alkyl (1 to 22 carbon atoms) phenyl ether, ( Poly) oxyalkylene (2 to 8 carbon atoms) alkyl (8 to 24 carbon atoms) amino ether and alkyl (8 to 24 carbon atoms) dialkyl (1 to 6 carbon atoms) amine oxide [lauryl dimethylamine oxide and the like] It is done.
前記両性界面活性剤としては、ベタイン型両性界面活性剤[ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ラウリルジメチルアミノ酢酸ベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルヒドロキシスルホベタイン、ラウロイルアミドエチルヒドロキシエチルカルボキシメチルベタインヒドロキシプロピルリン酸ナトリウム等]、アミノ酸型両性界面活性剤[β−ラウリルアミノプロピオン酸ナトリウム等]が挙げられる。 Examples of the amphoteric surfactant include betaine-type amphoteric surfactants [coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine, lauryldimethylaminoacetic acid betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryl. Hydroxysulfobetaine, lauroylamidoethylhydroxyethylcarboxymethylbetaine hydroxypropyl phosphate sodium and the like], and amino acid type amphoteric surfactants [sodium β-laurylaminopropionate and the like].
前記カチオン性界面活性剤としては、テトラアルキル(炭素数1〜18)アンモニウム塩(但し、後述の、本発明の抗菌剤以外の抗菌剤として例示したものは除く)、アルキル(炭素数1〜4)硫酸高級脂肪酸アミノアルキル(炭素数2〜4)トリアルキル(炭素数1〜4)アンモニウム塩[(エチル硫酸ラノリン脂肪酸アミノプロピルエチルジメチルアンモニウム等)]等が挙げられる。
さらには、米国特許第4,331,447号明細書に記載のアニオン性界面活性剤、両性界面活性剤、カチオン性界面活性剤およびノニオン性界面活性剤も挙げられる。
Examples of the cationic surfactant include tetraalkyl (C1 to C18) ammonium salts (except those exemplified as antibacterial agents other than the antibacterial agent of the present invention described later), alkyl (C1 to C4). ) Higher fatty acid aminoalkyl sulfate (2 to 4 carbon atoms) trialkyl (1 to 4 carbon atoms) ammonium salt [(such as ethyl lanolin sulfate fatty acid aminopropylethyldimethylammonium)] and the like.
Further, anionic surfactants, amphoteric surfactants, cationic surfactants and nonionic surfactants described in US Pat. No. 4,331,447 are also included.
前記キレート剤としては、エデト酸、ポリリン酸、ピロリン酸、グルコン酸およびこれらの塩などが挙げられる。
前記pH調整剤としては、例えば、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム、乳酸、コハク酸、クエン酸等が挙げられる。
前記清涼剤としては、例えば、L−メントール、カンフル等が挙げられる。
Examples of the chelating agent include edetic acid, polyphosphoric acid, pyrophosphoric acid, gluconic acid, and salts thereof.
Examples of the pH adjuster include potassium carbonate, sodium hydrogen carbonate, ammonium hydrogen carbonate, lactic acid, succinic acid, citric acid and the like.
Examples of the refreshing agent include L-menthol and camphor.
前記美白剤としては、例えば、グルタチオン、ハイドロキノン、ハイドロキノンの誘導体、レゾルシン、レゾルシンの誘導体、グラブレン等が挙げられる。 Examples of the whitening agent include glutathione, hydroquinone, hydroquinone derivatives, resorcin, resorcin derivatives, and globrene.
前記保湿剤としては、例えば、グリセリン、ポリエチレングリコール、ソルビトール、乳酸ナトリウム、ピロリドンカルボン酸ナトリウム、ヒアルロン酸ナトリウム、コンドロイチン硫酸塩などが挙げられる。 Examples of the humectant include glycerin, polyethylene glycol, sorbitol, sodium lactate, sodium pyrrolidonecarboxylate, sodium hyaluronate, chondroitin sulfate, and the like.
前記コンディショニング剤としては、例えば重量平均分子量500〜500万の範囲のカチオン化セルロース、カチオン化グアーガム、シリコーン類、ポリエチレングリコール、ポリアクリル酸ナトリウム、ヒドロキシエチルセルロース、タンパク質誘導体、セラミド類、擬似セラミド類、18−メチルエイコサン等の直鎖状又は分枝状の炭素数16〜40の脂肪酸、ヒドロキシ酸、パンテノール等が挙げられる。 Examples of the conditioning agent include cationized cellulose, cationized guar gum, silicones, polyethylene glycol, sodium polyacrylate, hydroxyethyl cellulose, protein derivatives, ceramides, pseudoceramides having a weight average molecular weight in the range of 5 to 5 million, 18 -Linear or branched fatty acids having 16 to 40 carbon atoms such as methyl eicosane, hydroxy acids, panthenol and the like.
前記香料としては、例えば、d−リモネン、β−カリオフィレン、シス−3−ヘキセノール、リナロール、ファルネソール、β−フェニルエチルアルコール,2,6−ノナジエナール、シトラール、α−ヘキシルシンナミックアルデヒド、β−イオノン、l−カルボン、シクロペンタデカノン、リナリルアセテート、ベンジルベンゾエート、γ−ウンデカラクトン、オイゲノール、ローズオキサイド、インドール、フェニルアセトアルデヒドジメチルアセタール、オーランチオール、シンアミックアルデヒド、メチルヨノンジャコウ、アニス精油、ケイ皮精油、ジャスミン精油等が挙げられる。 Examples of the perfume include d-limonene, β-caryophyllene, cis-3-hexenol, linalool, farnesol, β-phenylethyl alcohol, 2,6-nonadienal, citral, α-hexylcinnamaldehyde, β-ionone, l-carvone, cyclopentadecanone, linalyl acetate, benzylbenzoate, γ-undecalactone, eugenol, rose oxide, indole, phenylacetaldehyde dimethyl acetal, auran thiol, symamic aldehyde, methyl ionone musk, anise essential oil, silica Skin essential oil, jasmine essential oil, etc. are mentioned.
前記着色料としては、例えば、青色1号、青色2号、緑色3号、赤色1号等が挙げられ、化粧品に使用することができるものは、全て使用可能である。 Examples of the colorant include Blue No. 1, Blue No. 2, Green No. 3, Red No. 1 and the like, and all those that can be used for cosmetics can be used.
本発明の化粧品中の水以外の成分中における上記の任意成分の好ましい含有量は、それぞれ以下の通りである。
油剤、シリコーン化合物、アルコール類、アニオン性界面活性剤、ノニオン性界面活性剤、両性界面活性剤、カチオン性界面活性剤および保湿剤は、好ましくはそれぞれ50重量%以下、さらに好ましくは30重量%以下である。
キレート剤、ゲル化剤、美白剤およびコンディショニング剤は、好ましくはそれぞれ20重量%以下、さらに好ましくは10重量%以下である。
pH調整剤、清涼剤、香料および着色料は、好ましくはそれぞれ10重量%以下、さらに好ましくは5重量%以下である。
The preferred contents of the above optional components in the components other than water in the cosmetic of the present invention are as follows.
The oil agent, silicone compound, alcohol, anionic surfactant, nonionic surfactant, amphoteric surfactant, cationic surfactant and humectant are each preferably 50% by weight or less, more preferably 30% by weight or less. It is.
The chelating agent, gelling agent, whitening agent and conditioning agent are each preferably 20% by weight or less, more preferably 10% by weight or less.
The pH adjusting agent, the refreshing agent, the fragrance and the coloring agent are each preferably 10% by weight or less, more preferably 5% by weight or less.
また、本発明の化粧品には、必要に応じて本発明の抗菌剤以外の抗菌剤を併用してもよい。本発明の抗菌剤以外の抗菌剤としては、例えば、安息香酸およびその塩、サリチル酸およびその塩、デヒドロ酢酸およびその塩、イソプロピルメチルフェノール、パラベン、2−フェノキシエタノール、第4級アンモニウム塩(塩化ベンザルコニウム、塩化ベンゼトニウム、塩化アルキルトリメチルアンモニウムなど)、ポリヘキサメチレンビグアニリド、グルクロン酸クロルヘキシジン、ポリリジン並びに2−(4−チオシアノメチルチオ)ベンズイミダゾールなどが挙げられる。
本発明の抗菌剤以外の抗菌剤を併用する場合の併用の割合は、本発明の抗菌剤100重量部に対して100重量部以下、好ましくは50重量部以下である。
Moreover, you may use together antibacterial agents other than the antibacterial agent of this invention with the cosmetics of this invention as needed. Antibacterial agents other than the antibacterial agent of the present invention include, for example, benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and its salts, isopropylmethylphenol, paraben, 2-phenoxyethanol, quaternary ammonium salts (benzalkco chloride). Nium, benzethonium chloride, alkyltrimethylammonium chloride, etc.), polyhexamethylene biguanilide, chlorhexidine glucuronate, polylysine, and 2- (4-thiocyanomethylthio) benzimidazole.
The ratio of the combined use when the antibacterial agent other than the antibacterial agent of the present invention is used in combination is 100 parts by weight or less, preferably 50 parts by weight or less with respect to 100 parts by weight of the antibacterial agent of the present invention.
本発明の化粧品は、本発明の抗菌剤の含有量が化粧品中に0.01〜3重量%になるように含有するのが好ましく、さらに好ましくは0.01〜2重量%、特に0.01〜0.8重量%になるように含有するのが好ましい。
また、本発明の化粧品は、本発明の抗菌剤の含有量が化粧品中の水以外の成分中に0.01〜5重量%になるように含有するのが好ましく、さらに好ましくは0.01〜3重量%、特に0.01〜1.5重量%になるように含有するのが好ましい。
The cosmetic product of the present invention is preferably contained so that the content of the antibacterial agent of the present invention is 0.01 to 3% by weight in the cosmetic product, more preferably 0.01 to 2% by weight, particularly 0.01%. It is preferable to contain so that it may become -0.8weight%.
The cosmetic of the present invention is preferably contained so that the content of the antibacterial agent of the present invention is 0.01 to 5% by weight in components other than water in the cosmetic, more preferably 0.01 to The content is preferably 3% by weight, particularly 0.01 to 1.5% by weight.
本発明の化粧品における水の含有量は、化粧品の種類に応じて適宜選択されるが、化粧品の重量に基づいて、通常99重量%以下、好ましくは0〜98重量%である。また、本発明の化粧品の固形分濃度(水以外の成分の割合)は、通常1〜100重量%、好ましくは2〜100重量%である。 The content of water in the cosmetic of the present invention is appropriately selected depending on the type of cosmetic, but is usually 99% by weight or less, preferably 0 to 98% by weight, based on the weight of the cosmetic. Moreover, the solid content concentration (ratio of components other than water) of the cosmetic of the present invention is usually 1 to 100% by weight, preferably 2 to 100% by weight.
本発明品の化粧品の具体的な用途は特に限定はないが、例えば、乳液、クリーム、ローション、クレンジング料等の基礎化粧品;洗顔剤、全身洗浄剤、シャンプー等の洗浄料;ヘアートリートメント、リンス、コンディショナー、育毛剤、養毛剤等の頭髪化粧剤;ファンデーション、口紅、アイシャドウ等のメーキャップ化粧品;制臭剤等が挙げられる。 The specific use of the cosmetic product of the present invention is not particularly limited. For example, basic cosmetics such as milky lotion, cream, lotion, cleansing agent, etc .; cleansing agents such as face wash, whole body cleaner, shampoo; hair treatment, rinse, Hair conditioners such as conditioners, hair restorers and hair nourishing agents; makeup cosmetics such as foundations, lipsticks and eye shadows; and odorants.
<実施例>
以下、実施例を以て本発明を具体的に説明するが、本発明はこれらに限定されない。以下、部は重量部を意味する。
(A)におけるアルキレンオキサイドの付加モル数の分布は、試料を過剰のフェニルイソシアネート(試薬特級)と反応させて水酸基をラベル化した後、前述の液体クロマトグラフィーによって、下記の条件で測定した。
機 種;島津製作所製 LC−10ADVP
カラム:μ−Porasil(Waters)
移動相;2%イソプロピルアルコール/ブチルクロライド〜
32%イソプロピルアルコール/ブチルクロライド
までグラディエント
検出器;UV(240nm)
温 度;40℃
各付加モル数のピークの面積をそれぞれ該当する付加モル数の化合物の分子量で割ったときの値の比を各付加モル数の重量比とし、その値に基づいて各付加モル数の重量%を算出した。
<Example>
EXAMPLES Hereinafter, although an Example demonstrates this invention concretely, this invention is not limited to these. Hereinafter, the part means part by weight.
The distribution of the number of added moles of alkylene oxide in (A) was measured under the following conditions by the liquid chromatography described above after the sample was reacted with excess phenyl isocyanate (special reagent grade) to label the hydroxyl groups.
Model: LC-10ADVP manufactured by Shimadzu Corporation
Column: μ-Porasil (Waters)
Mobile phase: 2% isopropyl alcohol / butyl chloride
Gradient detector up to 32% isopropyl alcohol / butyl chloride; UV (240 nm)
Temperature: 40 ° C
The ratio of the value obtained by dividing the peak area of each added mole number by the molecular weight of the corresponding added mole number compound is defined as the weight ratio of each added mole number, and the weight percent of each added mole number is calculated based on that ratio. Calculated.
実施例1
撹拌及び温度調節機能の付いたガラス製オートクレーブに、1,2−ジヒドロキシドデカン202部(1モル部)、水酸化カリウム0.1部を投入し、混合系内を窒素で置換した後、減圧下(約20mmHg)、120℃にて1時間脱水を行った。次いでEO30.8部(0.7モル部)を150℃にて、ゲージ圧が1〜3kgf/cm2となるように導入した。反応物に「キョーワード600」を3部投入し、90℃にて触媒を吸着処理後、ろ過により1,2−ジオールアルキレンオキサイド付加物(A−1)を得た。
(A−1)の付加モル数分布は表1に示した。
Example 1
Into a glass autoclave with stirring and temperature control functions, 202 parts (1, 1 part by mole) of 1,2-dihydroxydodecane and 0.1 part of potassium hydroxide were added, and the inside of the mixed system was replaced with nitrogen. (About 20 mmHg) and dehydration were performed at 120 ° C. for 1 hour. Next, 30.8 parts (0.7 mol parts) of EO was introduced at 150 ° C. so that the gauge pressure was 1 to 3 kgf / cm 2. 3 parts of “Kyoward 600” was added to the reaction product, and the catalyst was adsorbed at 90 ° C., followed by filtration to obtain a 1,2-diol alkylene oxide adduct (A-1).
The added mole number distribution of (A-1) is shown in Table 1.
実施例2
撹拌及び温度調節機能の付いたガラス製オートクレーブに、1,2−ジヒドロキシデカン174部(1モル部)、過塩素酸アルミニウム9水塩0.1部を投入し、混合系内を窒素で置換した後、減圧下(約20mmHg)、120℃にて1時間脱水を行った。次いでEO55.0部(1.25モル部)を95℃にて、ゲージ圧が1〜2kgf/cm2となるように導入した。反応物に「キョーワード500(協和化学工業社製)」を2部投入し、90℃にて触媒を吸着処理後、ろ過により本発明の1,2−ジオールアルキレンオキサイド付加物(A−2)を得た。
(A−2)の付加モル数分布は表1に示した。
Example 2
In a glass autoclave with stirring and temperature control functions, 174 parts (1 mole part) of 1,2-dihydroxydecane and 0.1 part of aluminum perchlorate 9 hydrate were added, and the inside of the mixed system was replaced with nitrogen. Thereafter, dehydration was performed at 120 ° C. for 1 hour under reduced pressure (about 20 mmHg). Subsequently, 55.0 parts (1.25 mol parts) of EO were introduced at 95 ° C. so that the gauge pressure was 1 to 2 kgf / cm 2. 2 parts of “Kyoward 500 (manufactured by Kyowa Chemical Industry Co., Ltd.)” was added to the reaction product, and after the catalyst was adsorbed at 90 ° C., the 1,2-diol alkylene oxide adduct (A-2) of the present invention was filtered. Got.
The added mole number distribution of (A-2) is shown in Table 1.
実施例3〜6および比較例1
原料の1,2−ジオールの種類と量、および触媒としての水酸化カリウムの量、およびアルキレンオキサイドの種類と量を表1に示したように代えたこと以外は実施例1と同様にして実施例3〜6および比較例1の1,2−ジオールアルキレンオキサイド付加物(A−3)〜(A−6)および(X−1)を得た。これらの付加モル数分布は表1に示した。
表1中の略号は以下の通り。
6D:1,2−ジヒドロキシ−n−ヘキサン
8D:1,2−ジヒドロキシ−n−オクタン
10D:1,2−ジヒドロキシ−n−デカン
12D:1,2−ジヒドロキシ−n−ドデカン
16D:1,2−ジヒドロキシ−n−ヘキサデカン
24D:1,2−ジヒドロキシ−n−テトラエイコサン
EO:エチレンオキサイド
PO:1,2−プロピレンオキサイド
Examples 3 to 6 and Comparative Example 1
The same procedure as in Example 1 was conducted except that the type and amount of 1,2-diol as a raw material, the amount of potassium hydroxide as a catalyst, and the type and amount of alkylene oxide were changed as shown in Table 1. The 1,2-diol alkylene oxide adducts (A-3) to (A-6) and (X-1) of Examples 3 to 6 and Comparative Example 1 were obtained. These added mole number distributions are shown in Table 1.
Abbreviations in Table 1 are as follows.
6D: 1,2-dihydroxy-n-hexane 8D: 1,2-dihydroxy-n-octane 10D: 1,2-dihydroxy-n-decane 12D: 1,2-dihydroxy-n-dodecane 16D: 1,2- Dihydroxy-n-hexadecane 24D: 1,2-dihydroxy-n-tetraeicosane EO: ethylene oxide PO: 1,2-propylene oxide
(A−1)〜(A−6)、並びに、比較としての(X−1)、10D(1,2−ジヒドロキシ−n−デカン)、12D(1,2−ジヒドロキシ−n−ドデカン)、パラベンおよび2−フェノキシエタノールを用いて、抗菌性および皮膚刺激性の評価を行った。試験方法は以下の通りであり、結果を表2に示した。 (A-1) to (A-6), and (X-1), 10D (1,2-dihydroxy-n-decane), 12D (1,2-dihydroxy-n-dodecane), paraben as comparisons And 2-phenoxyethanol were used to evaluate antibacterial and skin irritation. The test method is as follows, and the results are shown in Table 2.
<抗菌性>
抗菌性を最小発育阻止濃度(MIC)試験により評価した。即ち、培地としてHeart infusion broth(HIB)を用い、希釈法(参考;東京大学医科学研究所学友会編 微生物学実習提要)に従って測定した。上記の抗菌剤またはこれらの配合物をHIBを用いて希釈し、濃度25ppm〜0.39ppm溶液を作製した。被検菌株大腸菌の一夜培養液(培地;HIB菌数 10℃ CFU/ml)50μlを加え、37℃にて一夜培養した。その後、被検菌の増殖の有無を観察し発育する阻止最小薬剤濃度(MIC)を求めた。
<Antimicrobial properties>
Antibacterial properties were evaluated by the minimum inhibitory concentration (MIC) test. In other words, Heart infusion broth (HIB) was used as a medium, and measurement was performed according to a dilution method (reference; microbial science practical training edited by the Institute of Medical Science, University of Tokyo). The above antibacterial agents or these blends were diluted with HIB to prepare a solution having a concentration of 25 ppm to 0.39 ppm. 50 μl of an overnight culture solution of the test strain Escherichia coli (medium; number of HIB bacteria 10 ° C. CFU / ml) was added and cultured overnight at 37 ° C. Thereafter, the minimum inhibitory drug concentration (MIC) for observing the growth of the test bacteria to grow was determined.
<皮膚刺激性>
上記の抗菌剤について、皮膚刺激性を男女各5名によるクローズド・バッチ試験(48時間後、上腕内側)を行い、次の基準で評価し、その合計点を表2に示した。
0:紅班なし
1:ごく軽度な紅班
2:明瞭な紅班
3:中程度から強度の紅班
4:肉様の紅班
<Skin irritation>
The antibacterial agent was evaluated for skin irritation by a closed batch test (48 hours later, inside the upper arm) by 5 men and women, and evaluated according to the following criteria.
0: No erythema 1: Very mild erythema 2: Clear erythema 3: Medium to strong erythema 4: Meat-like erythema
本発明の抗菌剤または比較例の抗菌剤を用いて下記の化粧品を作製し、皮膚刺激性を評価した。
<エモリエント乳液(O/W型)>
スクアラン 5.0
グリセリン 4.0
ポリオキシエチレン(20)グリセリルトリイソステアレート 2.0
PEG−6000 0.5
抗菌剤 0.1
香料 0.1
精製水 バランス
スクアラン、グリセリンおよびポリオキシエチレン(20)グリセリルトリイソステアレートを70℃に加熱しながら攪拌して油相を調製し、別の容器でその他の成分を70℃に加熱して溶解させた水溶液を上記の油相に攪拌しながら加えて乳化させた。
The following cosmetics were prepared using the antibacterial agent of the present invention or the antibacterial agent of the comparative example, and the skin irritation was evaluated.
<Emollient emulsion (O / W type)>
Squalane 5.0
Glycerin 4.0
Polyoxyethylene (20) glyceryl triisostearate 2.0
PEG-6000 0.5
Antibacterial agent 0.1
Fragrance 0.1
Purified water Balance squalane, glycerin and polyoxyethylene (20) glyceryl triisostearate are stirred while heating to 70 ° C to prepare an oil phase, and other components are heated to 70 ° C and dissolved in another container. The aqueous solution was added to the oil phase with stirring and emulsified.
得られたエモリエント乳液を、女性10名によって実使用し、使用後のヒリヒリ感を次の基準で評価した。
0:全然ヒリヒリしない
1:わずかにヒリヒリする
2:かなりヒリヒリする
The obtained emollient emulsion was actually used by 10 women, and the tingling feeling after use was evaluated according to the following criteria.
0: Not tingling at all 1: Slightly tingling 2: Slightly tingling
<保湿クリーム>
スクワラン 12.0
ホホバ油 4.2
パラフィン 3.0
ベヘニルアルコール 2.2
1,3−ブチレングリコール3.2 3.2
ステアリン酸 4.0
セタノール 2.0
ポリオキシエチレン(15)グリセリルモノステアレート 2.0
抗菌剤 0.3
精製水 バランス
<Moisturizing cream>
Squalane 12.0
Jojoba oil 4.2
Paraffin 3.0
Behenyl alcohol 2.2
1,3-butylene glycol 3.2 3.2
Stearic acid 4.0
Cetanol 2.0
Polyoxyethylene (15) glyceryl monostearate 2.0
Antibacterial agent 0.3
Purified water balance
得られた保湿クリームを、女性10名によって実使用し、使用後のピリピリ感を以下の基準で評価した。
0:全然ピリピリしない
1:わずかにピリピリする
2:かなりピリピリする
The obtained moisturizing cream was actually used by 10 women, and the tingling sensation after use was evaluated according to the following criteria.
0: Not tingling at all 1: Slightly tingling 2: Slightly tingling
本発明の抗菌剤は、化粧品、医薬品、飲料、木材およびプラスチックなどの各種の用途の抗菌剤として利用可能である。特に化粧品、例えば、乳液、クリーム、ローション、クレンジング料等の基礎化粧品;洗顔剤、全身洗浄剤、シャンプー等の洗浄料;ヘアートリートメント、リンス、コンディショナー、育毛剤、養毛剤等の頭髪化粧剤;ファンデーション、口紅、アイシャドウ等のメーキャップ化粧品;制臭剤等に有用である。 The antibacterial agent of the present invention can be used as an antibacterial agent for various uses such as cosmetics, pharmaceuticals, beverages, wood and plastics. In particular, cosmetics, for example, basic cosmetics such as emulsions, creams, lotions, cleansing agents, etc .; cleansing agents such as facial cleansers, whole body cleaners, shampoos, etc .; Useful in makeup cosmetics such as lipsticks and eye shadows;
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006242088A JP4991220B2 (en) | 2006-09-06 | 2006-09-06 | Antibacterial agent for cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006242088A JP4991220B2 (en) | 2006-09-06 | 2006-09-06 | Antibacterial agent for cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008063271A true JP2008063271A (en) | 2008-03-21 |
JP4991220B2 JP4991220B2 (en) | 2012-08-01 |
Family
ID=39286279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006242088A Expired - Fee Related JP4991220B2 (en) | 2006-09-06 | 2006-09-06 | Antibacterial agent for cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4991220B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214322A (en) * | 2007-03-08 | 2008-09-18 | Sanyo Chem Ind Ltd | Hair treatment agent composition |
WO2011052113A1 (en) * | 2009-10-28 | 2011-05-05 | 三洋化成工業株式会社 | Anti-bacterial agent |
DE102011077063A1 (en) * | 2011-06-07 | 2012-12-13 | Beiersdorf Ag | Active substance combination useful in cosmetic composition, preferably cosmetic deodorants, comprises epsilon polylysine, and an aromatic alcohol |
JP2013170131A (en) * | 2012-02-20 | 2013-09-02 | Sanyo Chem Ind Ltd | Composition for external use |
JP2017145241A (en) * | 2016-02-12 | 2017-08-24 | 三洋化成工業株式会社 | Antibacterial agent |
JP6739129B1 (en) * | 2020-05-22 | 2020-08-12 | 竹本油脂株式会社 | Spreading agent for waterborne floating pesticide composition and pesticide composition containing the same |
JP6739128B1 (en) * | 2020-05-22 | 2020-08-12 | 竹本油脂株式会社 | Granulating property improving agent for agrochemical composition and agrochemical composition using the same |
KR20210015759A (en) | 2018-05-31 | 2021-02-10 | Vb 재팬 테크놀로지 가부시키가이샤 | Antibacterial/antiviral composition and aqueous solution |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5449322A (en) * | 1977-09-26 | 1979-04-18 | Daicel Chem Ind Ltd | Non-medical anti-bacterial and anti-mold agent |
JP2007131594A (en) * | 2005-11-11 | 2007-05-31 | Adeka Corp | Antibacterial composition and cosmetic and cleanser each containing the same |
JP2007161651A (en) * | 2005-12-14 | 2007-06-28 | Adeka Corp | Antimicrobial agent and antimicrobial composition comprising the same |
-
2006
- 2006-09-06 JP JP2006242088A patent/JP4991220B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5449322A (en) * | 1977-09-26 | 1979-04-18 | Daicel Chem Ind Ltd | Non-medical anti-bacterial and anti-mold agent |
JP2007131594A (en) * | 2005-11-11 | 2007-05-31 | Adeka Corp | Antibacterial composition and cosmetic and cleanser each containing the same |
JP2007161651A (en) * | 2005-12-14 | 2007-06-28 | Adeka Corp | Antimicrobial agent and antimicrobial composition comprising the same |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214322A (en) * | 2007-03-08 | 2008-09-18 | Sanyo Chem Ind Ltd | Hair treatment agent composition |
WO2011052113A1 (en) * | 2009-10-28 | 2011-05-05 | 三洋化成工業株式会社 | Anti-bacterial agent |
DE102011077063A1 (en) * | 2011-06-07 | 2012-12-13 | Beiersdorf Ag | Active substance combination useful in cosmetic composition, preferably cosmetic deodorants, comprises epsilon polylysine, and an aromatic alcohol |
JP2013170131A (en) * | 2012-02-20 | 2013-09-02 | Sanyo Chem Ind Ltd | Composition for external use |
JP2017145241A (en) * | 2016-02-12 | 2017-08-24 | 三洋化成工業株式会社 | Antibacterial agent |
KR20210015759A (en) | 2018-05-31 | 2021-02-10 | Vb 재팬 테크놀로지 가부시키가이샤 | Antibacterial/antiviral composition and aqueous solution |
US11985971B2 (en) | 2018-05-31 | 2024-05-21 | VB JAPAN TECHNOLOGY Co., LTD. | Antibacterial and antiviral composition, aqueous solution, soaps, sanitary product, house detergent, kitchen detergent, clothing detergent, antibacterial and antiviral agent for house, antibacterial and antiviral agent for kitchen, antibacterial and antiviral agent for clothes, cosmetics, wet wipe, and wet hand towel |
JP6739129B1 (en) * | 2020-05-22 | 2020-08-12 | 竹本油脂株式会社 | Spreading agent for waterborne floating pesticide composition and pesticide composition containing the same |
JP6739128B1 (en) * | 2020-05-22 | 2020-08-12 | 竹本油脂株式会社 | Granulating property improving agent for agrochemical composition and agrochemical composition using the same |
Also Published As
Publication number | Publication date |
---|---|
JP4991220B2 (en) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4991220B2 (en) | Antibacterial agent for cosmetics | |
US9579272B2 (en) | Alkyl glycoside-based micellar thickeners for surfactant systems | |
JP4912483B2 (en) | Concentrated liquid detergent composition and method for producing the same | |
CN107011164A (en) | The polyglycerol ester of crosslinking | |
US20100132132A1 (en) | Quaternized cellulose ethers for personal care products | |
EP1810657A1 (en) | Hair care preparations | |
EP3357480B1 (en) | Microemulsion-type cosmetic and method for manufacturing same | |
EP1739161B1 (en) | Foam-enhancing agent | |
JP2011057647A (en) | Cosmetic | |
US20230348514A1 (en) | New rhamnolipid oligo-esters | |
WO2011052113A1 (en) | Anti-bacterial agent | |
KR20210065960A (en) | Method for producing glyceryl ether-containing composition and glyceryl ether-containing composition | |
JP5189836B2 (en) | Oil-containing cosmetic composition | |
JPWO2019187703A1 (en) | Underwater oil drop type fine emulsion type cosmetics | |
JP6407839B2 (en) | Antibacterial method of cosmetics | |
EP1689351A1 (en) | Ethoxylated polyurethane viscosity enhancers | |
JP5832930B2 (en) | Composition for external use | |
JP6843640B2 (en) | Antibacterial agent | |
JP4824517B2 (en) | Composition for external use | |
JP7039967B2 (en) | Acyl amino acid high compound composition | |
JP7039968B2 (en) | Acyl amino acid high compound composition | |
JP6105870B2 (en) | Nonionic surfactant composition, method for producing the same, and cosmetics and external preparations using the same | |
JP2012219122A (en) | Novel silicone derivative | |
EP3714946A1 (en) | Topical preparations comprising polyalkoxylated polyols polyester with guerbet acid | |
JP5711520B2 (en) | Composition for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090710 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120306 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120424 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120507 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4991220 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150511 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |